C. burnetii (Cb) is an obligate intracellular bacterial pathogen that replicates within alveolar macrophages following aerosol infection. Unlike most intracellular bacteria, Cb establishes a lysosome-derived replicative niche (Coxiella-containing vacuole or CCV) through the action of its Type IVB secretion system (T4BSS). This system translocates a large repertoire of effector proteins into the host cytoplasm after phagosome acidification. These effectors interfere with diverse signaling pathways to co-opt host processes, such as vesicle trafficking, ubiquitylation, gene expression and lipid metabolism, promoting pathogen survival without triggering robust proinflammatory signaling or host cell death pathways. This effector-triggered immune silencing is particularly unique given the central role of macrophages as innate immune sentinels. In this review, we examine Cb T4BSS effectors that have been characterized as central determinants of innate immunity modulation. We discuss innate immune sensing pathways potentially engaged during infection, including Toll-like receptors, NOD-like receptors, RIG-I-like receptors, inflammasomes, and interferon signaling pathways, and highlight evidence indicating that these pathways are actively suppressed. Emphasis is placed on effector-mediated regulation of NF-κB signaling, type I interferon responses, and inflammasome activation. Finally, we address unresolved questions related to effector-triggered immunity, redundancy in immune suppression, and discrepancies between in vitro and in vivo infection models.
Recently, the rising frequency in the abuse of synthetic cannabinoids (SCBs) has resulted in the occurrence of numerous severe adverse effects. We have previously shown that several early generations of SCBs undergo extensive metabolism by cytochrome P450s (P450s) and that their metabolites retain biological activity at CB1 and CB2 receptors. In this study, we examined the oxidative metabolism of 5F‐AKB‐48, one of a new structural generation of SCBs. Activity towards 5F‐AKB‐48 was investigated using various human microsomes followed by studies utilizing multiple recombinant human P450s. Screening with these enzymes showed that only 4, CYP2D6, −2J2, −3A4, and −3A5, biosynthesized the 2 major products, mono‐ and dihydroxylated 5F‐AKB‐48, with activities in the range of 2–5 pmol/min/pmol CYP. CYP3A5 formed the most dihydroxylated metabolite, whereas CYP2J2, highly expressed in cardiovascular tissues, showed the biosynthesized the most monohydroxylated derivative. CYP2D6 produced only monohydroxylated derivatives whereas CYP3A4 produced mostly dihydroxylated ones. To elucidate the roles of CYP3A4 and CYP3A5, additional enzymatic reactions utilized genotyped HLMs containing normal activity for CYP3A4 but low or high activities of CYP3A5. Those experiments resulted in significantly different patterns of oxidized metabolites. An UPLC equipped with UV/Vis detector and/or MS/MS were used to analyze the reactions. The profiles of the products biosynthesized were significantly different between the fluorinated and unfluorinated analogs. As this structural difference is known to increase potency for CB1 receptors, understanding the involved mechanism is essential. In conclusion, extensive metabolic studies of SCBs, including investigation of the mechanism(s) of action leading to toxicity, could result in the development of life saving, efficacious treatments for SCB abuse. Support or Funding Information (INBRE 117‐1006096 2018 AP and NIH/NIDA DA039143 to ARP and PLP) This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .